Tumor necrosis factor alpha levels in plasma and whole-blood culture in dengue-infected patients: Relationship between virus detection and pre-existing specific antibodies

Journal of Medical Virology

Volumn 54, Issue 3, 1998, Pages 210-218

  Hober, Didier ^a,h   Nguyen, Trong Lan ^b   Shen, Lu ^a,g   Ha, Do Quang ^c   Huong, Vu Thi Que ^c   Benyoucef, Samira ^a   Nguyen, Thanh Hung ^b   Bui, Thi Mai Phuong ^b   Loan, Huynh Kim ^c   Le, Bich Lien ^a   Bouzidi, Ahmed ^d   De Groote, Donat ^e   Drouet, Marie Thérèse ^f   Deubel, Vincent ^f   Wattré, Pierre ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Children's Hospital No 1   (Viet Nam)

^c PASTEUR INSTITUTE   (Viet Nam)

^d Laboratoire Francais du Fractionnement et des Biotechnologies   (France)

^e Medgenix Diagnostics SA   (Belgium)

^f INSTITUT PASTEUR   (France)

^g PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^h CHU Rouen BG   (France)

Author keywords

Anti dengue virus antibodies; RT PCR; Vietnam; Virus isolation

Indexed keywords

ANTIBODY; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY;

AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; HUMAN; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIET NAM; VIRUS DETECTION; VIRUS ISOLATION; VIRUS REPLICATION;

ADOLESCENT; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CHILD; CHILD, PRESCHOOL; DENGUE; FLAVIVIRUS; FOLLOW-UP STUDIES; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

DENGUE VIRUS; RNA VIRUSES;

EID: 0031934588     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199803)54:3<210::AID-JMV12>3.0.CO;2-L     Document Type: Article

References (36)

1. Adler H, Jungi TW, Pfister H, Strasser M, Sileghem M, Peterhans E (1996): Cytokine regulation by virus infection: bovine viral diarrhea virus a flavivirus, downregulates production of Tumor Necrosis Factor alpha in macrophages in vitro. Journal of Virology 70:2650-2653.
2. Allen JN, Herzyk DJ, Allen ED, Wewers MD (1992): Human whole blood interleukine-1-β production: kinetics, cell source and comparison with TNFα. Journal of Laboratory and Clinical Medicine 119:538-546.
3. Anderson R, Wang S, Osiowy C, Issekutz AC (1997): Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. Journal of Virology 71:4226-4232.
4. Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland S (1994): Serum levels of tumor necrosis factor-α (TNFα) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologic parameters. Journal of Infections Diseases 169:420-424.
5. Chang DM, Shaio MF (1994): Production of interleukin-1 (IL-1) and IL-1 inhibitor by human monocytes exposed to dengue virus. Journal of Infectious Diseases 170:811-817.
6. Chungue E, Burucoa C, Boutin JP, Philippon G, Laudon F, Plichart R, Barbazan P, Cardines R, Roux J (1992): Dengue 1 epidemic in French Polynesia, 1988-1989: surveillance and clinical, epidemiological virological and serological findings in 1752 documented clinical cases. Transactions of the Royal Society of Tropical Medicine and Hygiene 86:193-197.
7. Clarke DH, Casals J (1958): Techniques for haemagglutination and haemagglutination inhibition with arthropod-borne viruses. American Journal of Tropical Medicine and Hygiene 7:561-573.
8. Cohen SN, Halstead SB (1966): Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand. Journal of Pediatric 68:448-456.
9. Degroote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Franchimont I (1992): Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IFN-gamma and GM-CSF) in whole blood: I. Comparison with isolated PBMC stimulation. Cytokine 4:239-248.
10. Deubel V, Huerre M, Cathomas G, Drouet MT, Wusher N, Le Guenno B, Widmer AF (1997): Molecular detection and characterization of yellow fever virus in blood and liver specimens of a non-vaccinated fatal human case. Journal of Medical Virology (in press).
11. Halstead SB (1989): Antibody, macrophages, dengue virus infection, shock and hemorrhage: a pathogenic cascade. Review of Infectious Diseases 11(Suppl 4):S830-839.
12. Henchal EA, McCown, Seguin MC, Gentry MK, Brandt WE (1983): Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. American Journal of Tropical Medicine and Hygiene 32:164-169.
13. Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G, Imbert P, Pecarere JL, Vergez-Pascal R, Wattré P, Mainez-Montreuil M (1993): Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) in dengue-infected patients. American Journal of Tropical Medicine and Hygiene 48: 324-331.
14. Hober D, Shen L, Benyoucef S, De Groote D, Deubel V, Wattré P (1996): Enhanced TNFα production by monocytic-like cells exposed to dengue virus antigens. Immunology Letters 53:115-120.
15. Kliks S (1990): Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness. AIDS Research and Human Retroviruses 6:993-998.
16. Kuno GE, Bailey R (1994): Cytokine responses to dengue infection among Puerto Rican patients. Memorial Institute of Oswaldo Cruz 89:179-182.
17. Kurane I, Ennis FA (1994): Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue hemorrhagic fever. Seminars in Virology 5:443-448.
18. Kurane IL, Innis B, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA (1991): Activation of T lymphocytes in dengue virus infections: high levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon γ in sera of children with dengue. Journal of Clinical Investigation 88:1473-1480.
19. Lanciotti RS, Calisher CH, Gubler DJ, Chang G-J, Vorndam AV (1992): Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. Journal of Clinical Microbiology 30:545-551.
20. Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Moller A, Jacobsen H, Kirchner H (1986): Antiviral effects of recombinant tumor necrosis factor in vitro. Nature 323:816-818.
21. Monath TP (1994): Dengue: the risk to developed and developing countries. Proceedings of the National Academy of Sciences of the USA 91:2395-2400.
22. Morens DM, Halstead SB (1990): Measurement of antibody-dependent enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. Journal of General Virology 71: 2909-2914.
23. Munoz C, Carlet J, Fitting C, Misset B, Blériot J-P, Cavaillon J-M (1991): Dysregulation of in vitro cytokine production in monocytes during sepsis. Journal of Clinical Investigation 88:1747-1754.
24. Pang T (1987): Pathogenesis of dengue haemorrhagic fever: towards a more balanced view. Southeast Asian Journal of Tropical Medicine and Public Health 18:321-325.
25. Rosen L (1989): Disease exacerbetion caused by sequential dengue infections: myth or reality? Review of Infectious Diseases 11:5840-5842.
26. Sekut L, Menius A, Jr, Bracken MF, Conolly KM (1994): Evaluation of the significance of elevated levels of systemic and localized tumor necrosis factor in different animal models of inflammation. Journal of Laboratory and Clinical Medicine 124:813-820.
27. Steffen M, Reinecker HC, Petersen J, Doehn C, Pflüger I, Voss A, Raedler A (1993): Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients. Clinical and Experimental Immunology 91:30-36.
28. Suvatte V (1987): Immunological aspect of dengue haemorrhagic fever: studies in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 18:312-315.
29. Tracey KJ, Lowry SF, Cerami A (1988): Cachectin: a hormone that triggers acute shock and chronic cachexia. Journal of Infectious Diseases 157:413-420.
30. Vitarana T, De silva H, Withana N, Gunasekera C (1991): Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. Ceylon Medical Journal 36:63-65.
31. Von Asmuth EIU, Maessen JG, Van der linden CJ, Buurman WA (1990): Tumor necrosis factor alpha (TNF-α) and interleukin 6 in a zymosan induced shock model. Scandinavian Journal of Immunology 32:313-319.
32. Wallach D, Aderka D, Rubinstein M, Engelmann H, Shemer YS, Sarou I, Holtmann H, (1990): Mechanisms involved in regulation of the response to tumor necrosis factor. In Bonavida B, Granger G (eds): "Tumor Necrosis Factor: Structure, Mechanism of Action, Role in Disease and Therapy." Basel: Karger, pp 146-155.
33. Wilson BMG, Serven A, Rapson NT, Chana J, Hopkins P (1991): A convenient human whole blood culture system for studying the regulation of tumor necrosis factor release by bacterial lipopolysaccharide. Journal of Immunological Methods 139:233-240.
34. World Health Organization (1980): Technical advisory committee on dengue hemorrhagic fever for southeast Asian Western Pacific regions. Guide for diagnosis. Treatment and Control of dengue hemorrhagic fever. Geneva.
35. Yadav M, Kamath KR, Iyngkaran N, Sinniah M (1991): Dengue hemorrhagic fever and dengue shock syndrome: Are they tumor necrosis factor-mediated disorders? FEMS Microbiology and Immunology 4:45-49.
36. Yang KD, Lee CS, Hwang KP, Chu ML, Shaio MF (1995): A model to study cytokine profiles in primary and heterologously secondary dengue-2 virus infections. Acta Virologica 39:19-21.